Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravitreal aflibercept to laser photocoagulation in retinopathy of prematurity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Retinopathy of Prematurity | Phase 3 | Status: COMPLETED | Results posted: 2023-07-20